Autopsy report · NCT02079220

A Phase II Study of Ziv-aflibercept in Combination With Capecitabine/Oxaliplatin (XELOX) Chemotherapy in the Front-Line Treatment of Patients With Metastatic Colorectal Cancer

“Funding for the study was withdrawn, no participants were ever recruited.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2

Sponsor

James J Lee

Sponsor type

University, hospital or other

Conditions

Metastatic Colorectal Cancer

Interventions

Arm A; Arm B

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Utilizing a Promotora Model for Rural Adult Hispanics Diagnosed With Metabolic Syndrome: A Clinical Trial
  “Funding for the study was not received. No recruitment ever occurred.” (89% match in meaning)
• Assessing the Impact of Botulinum Toxin Type A on Facial Wrinkles: A Comprehensive Clinical Investigation
  “Study did not begin, and no participants were enrolled.” (89% match in meaning)
• Robotic Versus Open Comparison in the Surgical Treatment of Wide Abdominal Wall heRnias (ROCSTAR)
  “The study was not initiated and no participants were enrolled.” (88% match in meaning)
• Melatonin Supplementation to Improve Sleep in Patients With Heart Failure
  “No subjects were enrolled in this study. Funding ran out.” (87% match in meaning)
• Gastric and Autonomic Functions in Patients With Intragastric Balloon
  “The study did not recruit any participant.” (86% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.